These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20407012)

  • 1. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.
    Chadalapaka G; Jutooru I; Burghardt R; Safe S
    Mol Cancer Res; 2010 May; 8(5):739-50. PubMed ID: 20407012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin decreases specificity protein expression in bladder cancer cells.
    Chadalapaka G; Jutooru I; Chintharlapalli S; Papineni S; Smith R; Li X; Safe S
    Cancer Res; 2008 Jul; 68(13):5345-54. PubMed ID: 18593936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
    Jutooru I; Chadalapaka G; Lei P; Safe S
    J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
    Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
    Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
    Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S
    Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
    Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
    Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity Proteins (Sp) and Cancer.
    Safe S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
    Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
    Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.
    Nair V; Sreevalsan S; Basha R; Abdelrahim M; Abudayyeh A; Rodrigues Hoffman A; Safe S
    J Biol Chem; 2014 Oct; 289(40):27692-701. PubMed ID: 25143389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
    Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
    J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G; Jutooru I; Safe S
    Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S
    Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
    Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
    Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.
    Pathi S; Jutooru I; Chadalapaka G; Nair V; Lee SO; Safe S
    PLoS One; 2012; 7(10):e48208. PubMed ID: 23110215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
    Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
    Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
    Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
    Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
    Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.